Steven Powers, MD
Obstetrics & Gynecology · Chesapeake, VANPI 1255318069
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,333 of the $8,393 with a category attached, or 87.4%. It is spread thinly across 40 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Among obstetrics & gynecology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 346 payments — averaging $24.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$1K
- AbbVie$1K
- Astellas Pharma US Inc$978
- Intuitive Surgical$675
- Amgen$528
- Momentis Surgical Inc.$456
- plus $3K from 34 others
What the payments were for
- Travel & lodging$6758%
- Food & beverage$7,33387%
- Education$3855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 44 | $1,252 |
| AbbVie(2 entities) | 60 | $1,101 |
| Astellas Pharma US Inc | 35 | $978 |
| Intuitive Surgical | 5 | $675 |
| Amgen | 21 | $528 |
| Momentis Surgical Inc. | 7 | $456 |
| Hologic Sales And Service, LLC | 14 | $436 |
| Myovant Sciences Inc. | 19 | $407 |
| Sumitomo Pharma America, Inc. | 16 | $306 |
| Exeltis, USA Inc. | 12 | $242 |
| Mayne Pharma Commercial LLC | 8 | $225 |
| Organon | 12 | $215 |
| Novo Nordisk | 8 | $215 |
| Minerva Surgical, Inc | 13 | $190 |
| Bayer | 10 | $185 |
| Pfizer | 12 | $169 |
| Urovant Sciences Inc | 3 | $109 |
| Merck | 8 | $105 |
| Therapeuticsmd, Inc. | 4 | $57 |
| AMAG Pharmaceuticals, Inc. | 4 | $53 |
| Scynexis, Inc. | 3 | $49 |
| Avion Pharmaceuticals | 3 | $39 |
| Shield Therapeutics Inc | 1 | $36 |
| Lupin Inc. | 2 | $33 |
| Meditrina | 3 | $32 |
| Medtronic | 2 | $29 |
| Vertical Pharmaceuticals, LLC | 2 | $29 |
| Biogen | 2 | $28 |
| Johnson & Johnson | 1 | $23 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $23 |
| Coopersurgical, Inc. | 2 | $23 |
| Millicent US Inc | 1 | $19 |
| Mimedx Group, Inc. | 1 | $19 |
| Duchesnay USA Incorporated | 1 | $19 |
| Teleflex LLC | 1 | $16 |
| Dermira, Inc. | 1 | $16 |
| Alydia Health | 1 | $15 |
| Renovia Inc | 1 | $14 |
| Aspira Women's Health Inc | 1 | $13 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$577
- INJECTAFER$359
- Anovo Surgical System$355
- Orilissa$240
- EVENITY$232
- ACESSA PROVU SYSTEM$129
- Veozah$125
- Saxenda$121
- MYFEMBREE$118
- NEXTSTELLIS$100
How this compares
$8,393 in reported general payments places this provider in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 36 | $18,385 |
| MyrbetriqMirabegron | 15 | $10,670 |
| Raloxifene Hcl | 201 | $8,388 |
| LinzessLinaclotide | 13 | $7,895 |
| PremproEstrogen,con/M-Progest Acet | 14 | $7,107 |
| DuaveeEstrogens,conj/Bazedoxifene | 24 | $6,772 |
| Estradiol | 173 | $5,928 |
| ProgesteroneProgesterone, Micronized | 31 | $1,428 |
| DottiEstradiol | 12 | $738 |
| Clobetasol Propionate | 16 | $694 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 42 | $657 |
| Medroxyprogesterone Acetate | 15 | $581 |
| Fluconazole | 54 | $521 |
| ValacyclovirValacyclovir Hcl | 11 | $461 |
| Norethindrone | 16 | $431 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin, Prempro, Duavee | $169 | $32,26474 claims |
| Astellas Pharma US IncMyrbetriq | $978 | $10,67015 claims |
| AbbVieLinzess | $1,101 | $7,89513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.
Other obstetrics & gynecology in Chesapeake
- Bunan AlnaifChesapeake$139K
- Derwin GrayChesapeake$32K
- Linda Mathison EziemeChesapeake$5K
- Thomas KimbleNorfolk$286K
- Jack AyoubLeesburg$279K
- Kurian ThottStafford$216K
- Nina SmithHarrisonburg$199K
- Joseph TroiseSalem$144K
- James JonesRichmond$134K
- Melissa DelgadoVienna$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.